As the countdown begins to next Wednesday’s vote by the European Parliament’s lead committee ENVI on the proposed new EU Medical Device Regulation and IVD Regulation, there is speculation around whether the vote will be delayed yet again. If so, it would be the third time in three months1.
As the countdown begins to next Wednesday’s vote by the European Parliament’s lead committee ENVI on the proposed new EU Medical Device Regulation and IVD Regulation, there is speculation around whether the vote will be delayed yet again. If so, it would be the third time in three months1.
The 25 September date for the ENVI vote remains fixed on the committee’s website agenda. However, it seems the reason...
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.
AI-driven medtech M&A slowed slightly in volume but tripled in value in early 2025, with buyers focusing on AI-driven diagnostics, surgical tech and analytics. Industry experts expect continued high-value deals as firms defend market share and pursue workflow-enhancing AI.
Philips says the expansion of its facility in Reedsville, PA, will not only boost its capacity to produce AI-enabled ultrasounds that are used in hospitals across the US but will also create 120 well-paying jobs.
A government-backed program is working on improving the ability to run dementia clinical trials in the UK, and access to trials for participants.
